News
Watch this space for the latest News from Pharmora.
Men’s Health Week
Men’s Health Week is a global campaign to raise awareness of physical and mental health issues faced by men. Read on to hear from a Pharmora scientist on how increasing discussion around Men’s Health issues could help to save lives.
My Week at Phamora
Another account of our work experience opportunity at our head office in Macclesfield, where Nayana shadowed our medical scientists for a week. She was able to observe our day-to-day operations and even got the opportunity to contribute to multiple projects! Read all about it in Nayana’s blog.
Pharmora Goes Bowling!
The team was delighted to be invited to the opening of a new restaurant in the heart of Macclesfield. The Charles Roe Pub and Restaurant provided a welcoming setting for the team to come together, with delicious food and a great atmosphere.
After the meal, we headed to the bowling alley for some light-hearted competition, adding a fun and energetic finish to the evening. It was a lovely reminder of how valuable it can be to spend time together outside of the workplace.
Our Trip to Rossendale
Pharmora spent two rewarding days at Macclesfield Community Tree Nursery, helping with everything from watering and mulching to repotting larger trees while giving back to the local environment and community.
My time shadowing at Pharmora
One of our work experience students recently joined us at Pharmora for a few days. This blog tells us his perspective and account of his time spent with us.
The History of Clinical Trials
In this blog post to celebrate Clinical Trials Day 2026, we have written a short history of clinical trials as well as the key milestones leading to the standardisation and improvement in patient welfare.
Impact of Clinical Trial Reforms: Global and UK perspectives
Pharmora is pleased to present the 2nd blog in the series celebrating Clinical Trials Day! In this blog one of our Trainee Scientists discusses the latest reforms to clinical trials regulation, how these impact medicine developers globally, and how the UK has reacted to this update. Read on to find out more…
World Drug Safety Congress Europe 2025
Hear insights on the biggest safety congress this year, from our Chief Medical Officer Dr Stephanie Jones.
Medical Monitoring Masterclass: Where Safety Meets Scientific Rigour
The fifth and final instalment of our Medical Monitoring Masterclass, we’re focussing on medical monitoring in generics development.
Medical Monitoring Masterclass: Medical Monitoring in Biosimilar Development
In the fourth instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’re looking at why biosimilar trials require specialist monitoring along with immunogenicity – one of the most important considerations in biosimilar development.
Medical Monitoring Masterclass: Building a Trial That Investors Will Believe In
In the second instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’ve written a guide on medical monitoring for biotechs with some insights into why clinical trials are crucial.
Medical Monitoring Masterclass: What Quality Oversight Means for Your Asset
In the third instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’re looking at clinical risk and what quality oversight means for your asset.
Medical Monitoring Masterclass: What Is It and Why Does It Matter?
In celebration of Clinical Trials Day 2026, we have created a Medical Monitoring Masterclass. In this first instalment, we discuss the importance of medical monitoring and the changing regulatory landscape.
World Autism Day
In this blog raising awareness of autism in celebration of World Autism Day (2nd April), Dr Arunesh Sil has written about his experience raising his autistic child and all that it taught him about acceptance and patience.
Rare diseases are not rare!
In this blog to support Rare Disease Day Pharmora Chief Medical Officer, Dr Stephanie Jones, has provided tips for Innovators developing new products to diagnose or treat rare diseases, and a checklist to help people affected by these conditions who are looking for these innovations.
Ovarian Cancer (3 of 3): Treatments
In the final instalment of this masterclass, we explore current available treatment options and the treatments that are in development in both the laboratory and clinical trial stages.
Ovarian Cancer (2 of 3): Types & Statistics
In the second instalment of this masterclass, we discuss the wide variety of types and sub-types of ovarian cancer including the variations in symptoms and survival rates.
Ovarian Cancer (1 of 3): Signs & Symptoms
In the first instalment of this masterclass, we discuss the signs and symptoms that indicate ovarian cancer, along with the importance of bringing these symptoms to a healthcare professional as early as possible.
International Day of Women and Girls in Science (3 of 3)
This is the final instalment of our series of blogs which detail just a few women and girls’ experiences of being a woman in a scientific field. In this final blog, we hear from one of our staff about her journey from a scientifically-inclined child, to the scientist she is today.
International Day of Women and Girls in Science (2 of 3)
This is the second of our series of blogs which detail just a few women and girls’ experiences of being a woman in a scientific field. In this second instalment, we hear from one of our work experience students who’s studying A-Level Biology and is fighting for more recognition of women and girls in the sciences.
International Day of Women and Girls in Science (1 of 3)
This is the first of our series of blogs detailing just a few women and girls’ experiences of being a woman in a scientific field. In this first post, we hear from an inspired GCSE student who will be studying 2 sciences at A-Level with a brief foreword from our CMO, Dr Stephanie Jones.
Current and future treatments for HIV/AIDS, Medical Information (3 of 3)
In this 3rd and final blog of the series, Josh describes the current management of HIV/AIDS, discusses the medicines in development, and provides an insight into the health inequality impacting this condition.
International Epilepsy Awareness Day
Today we are celebrating International Epilepsy Day! By understanding the condition, we can support ongoing research and raise awareness for the 50 million people living with epilepsy globally.
Early treatments, the Stigma and HAART, Medical Information (2 of 3)
In our previous blog, we looked at the initial discovery of HIV, the mechanisms of how it infects CD4 cells and the human cost of the virus in the 1980s. Here, we will discuss the first treatments to become available for HIV, their side effects, the stigma associated with the disease and what that meant for patient prognosis, and the introduction of Highly Active Antiretroviral Therapy (HAART).
Celebrating the 10th Annual Global Campaign for Patient Safety
The much-anticipated MedSafetyWeek - now in its tenth year - is here! This year’s theme, “We can all help make medicines safer,” highlights the collective role we play in ensuring medicine safety. By reporting suspected adverse reactions to medicines and vaccines, and...
Conversations With Industry Leaders : Dr Sheuli Porkess
Dr Jones was delighted to meet with Dr Sheuli Porkess, Director of Actaros Consultancy and President of the Faculty of Pharmaceutical Medicine to talk about some hot topics in our industry! Read on to hear their insights on AI and the challenges of encouraging diversity in our industry…
Hereditary Cancer Awareness Week: Understanding Risk, Empowering Families
Hereditary Cancer Awareness Week raises awareness of inherited cancer risks such as BRCA and Lynch syndrome. Learn how family history, genetic testing, and new research in population screening and polygenic risk scores are shaping the future of cancer prevention.
World Patient Safety Day 2025: Patient Safety from the Start
This year’s World Patient Safety Day highlights “Patient safety from the start: safe care for every newborn and child”. We support safer outcomes for children and vulnerable patients through rigorous data review, pregnancy precautions, and paediatric safety expertise. Read more.
From Powerhouse to Patient Care: Understanding Mitochondrial Disease
Mitochondria are often called the “powerhouses” of our cells, but when their DNA carries variants, families can face difficult and lifelong health challenges. We are marking World Mitochondrial Disease Week with this educational blog – read on to learn more.
AI, machine learning, and the first BioAI conference from Bionow
AI in biosciences has been a developing topic for discussion at many recent conferences, so it was time it got its own! Read on to learn more about the BioAI conference…
National Schizophrenia Awareness Day – July 25th
Schizophrenia is a commonly misunderstood mental health condition which 1 in 300 people have worldwide. It is important to spread awareness this National Schizophrenia Awareness Day so those who need support can access it. Read on to find out more.
My Time at Pharmora (so far)
Learn what it’s like to be a part of the team at Pharmora, as Rhandel describes his first year at our organisation.
Conversations with Industry Leaders: Dr Sue Lim 1 April 2025
By Dr Stephanie-Jayne Jones
On 1st April I caught up with Dr Sue Lim in the latest in my series of “Conversations with Leaders in our Industry”. Dr Lim is an experienced former FDA director and licensed physician with around 2 decades of global drug development experience.
Conversation with Industry Leaders: Professor Alan Boyd 11 April 2025
Continuing conversations with industry leaders, CMO Dr Jones interviews Professor Alan Boyd, ex President of the FPM. Some of you will know him as the former President of the Faculty of Pharmaceutical Medicine, some will know him as the entrepreneur who created @Boyds and others will know him as an engaging and expert mentor, dedicated to training and empowering the next generation of people working in the pharmaceutical industry.
Introduction to HIV and patient outcomes – Medical Information, 1 of 3
In the first blog of this Master Class series, we will discuss the basics of HIV, including some of the history of its discovery and how it links to AIDS.
Understanding Gaucher Disease
Gaucher disease is a rare genetic disorder caused by a deficiency in the enzyme glucocerebrosidase, leading to a harmful buildup of fat in cells. This causes symptoms like enlarged organs, bone pain, and, in some cases, neurological impairment. Current treatments offer relief but come with limitations such as inconvenient infusions, side effects, and the inability to address neurological symptoms. Read on to discover the promising new developments bringing hope for this rare disease…
The MHRA’s Patient Involvement Strategy 2021-25
The MHRA launched the Patient Involvement Strategy 2021-2025. Now, in the final year of the strategy, what has been done for Patient Involvement, and what do the MHRA plan to do next? Read on to learn…
The EMA’s IRIS platform – what is it, and what does it mean for MAHs?
The EMA is transitioning all of the communications during the Marketing Authorisation process to its IRIS platform, read on to learn more about what this might mean for you.
Recent trends in the pharmaceutical industry: Patient-focus
In recent years, patient-centricity and patient-focus have been mentioned frequently in discussions about the future of the pharmaceutical industry. Pharmora have written a series of blogs to dissect and discuss this trend, read on to learn more…
Landscape of Sarcoma Treatments Development
Reflecting on the current landscape of oncological drug development, Pharmora would like to take this opportunity to raise awarenesses of rare cancers that need more attention. In this blog, we put a spotlight on Sarcoma, where we summarise what sarcoma cancer is, what is in development in the changing treatment landscape, and what could be done in the future.












